Injections can restore red blood cell levels and improve oxygen flow throughout the body
Smoother Results: The stimulation of collagen production promotes skin elasticity, enhancing the overall smoothness and firmness of treated areas
Saxenda (liraglutide 3.0 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for weight management in adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m with weight-related comorbidities
Key considerations for IM injections include: Using a needle of the right length to ensure the medication is delivered into the muscle Rotating injection sites to avoid muscle irritation Administering the injection at a 90-degree angle to the skin surface Subcutaneous Administration Benefits Subcutaneous injections put Vitamin B12 into the fatty tissue just under the skin
## **Other similar codes** - **J3262** - Injection, tocilizumab, 1 mg - **J3380** - Injection, vedolizumab, 1 mg - **J2357** - Injection, omalizumab, 5 mg - **J2323** - Injection, natalizumab, 1 mg Frequently asked questions